menu
    • menu

    Company profile for CRISPR Therapeutics

    NEW Drugs in Dev: 10
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases. We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-editing platform into therapies to treat hemoglobinopathies, cancer, diabetes and other diseases. Our multi-disciplinary team of world-class researchers and drug developers works every day to translate our CRISPR/Cas9 technology in...
    At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases. We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-editing platform into therapies to treat hemoglobinopathies, cancer, diabetes and other diseases. Our multi-disciplinary team of world-class researchers and drug developers works every day to translate our CRISPR/Cas9 technology into breakthrough human therapeutics. Our lead program targeting the blood diseases β-thalassemia and sickle cell disease has entered clinical testing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CRISPR TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    610 Main Street (enter on Portland Street), Cambridge, MA 02139
    Telephone
    Telephone
    617-315-4600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.crisprtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/crispr-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/crisprtx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    MAGHREB Pharma Expo

    MAGHREB Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    MAGHREB Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CRISPR Therapeutics to Present at 25th Needham Healthcare Conf
    CRISPR Therapeutics to Present at 25th Needham Healthcare Conf

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269071/0/en/CRISPR-Therapeutics-to-Present-at-the-25th-Annual-Needham-Virtual-Healthcare-Conference.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    CRISPR Therapeutics Prices Upsized Convertible Senior Notes
    CRISPR Therapeutics Prices Upsized Convertible Senior Notes

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253635/0/en/CRISPR-Therapeutics-Prices-Upsized-Convertible-Senior-Notes-Offering.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    CRISPR Therapeutics Proposes Convertible Senior Notes Offering
    CRISPR Therapeutics Proposes Convertible Senior Notes Offering

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252625/0/en/CRISPR-Therapeutics-Announces-Proposed-Convertible-Senior-Notes-Offering.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    CRISPR Therapeutics Updates Business And Releases 2025 Financials
    CRISPR Therapeutics Updates Business And Releases 2025 Financials

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237711/0/en/CRISPR-Therapeutics-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    CRISPR Highlights Strategic Priorities, Anticipated 2026
    CRISPR Highlights Strategic Priorities, Anticipated 2026

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216929/0/en/CRISPR-Therapeutics-Highlights-Strategic-Priorities-and-Anticipated-2026-Milestones.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    CRISPR Therapeutics To Present At J.P. Morgan Healthcare Conf
    CRISPR Therapeutics To Present At J.P. Morgan Healthcare Conf

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212778/0/en/CRISPR-Therapeutics-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search